Youcef M. Rustum - Concepedia

Author

Youcef M. Rustum

Roswell Park Comprehensive Cancer Center ORCID

Also Known As

Rustum, Youcef M., Y M Rustum, Y RUSTUM, Y Rustum, Y. M. RUSTUM, Y. M. Rustum, Y. RUSTUM, Y. Rustum, Y.M Rustum, Y.M. RUSTUM

306

Publications

9.9K

Citations

H-Index

136

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Grace (United States)

About

Youcef M. Rustum is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, cancer research, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	97	5.3K
2	Natural Sciences	14	14	800
3	Health Sciences	12	14	986
4	Engineering	4	4	80
5	Public Health	1	1	33

Youcef M. Rustum

156

Publications

8.6K

Citations

H-Index

Page 1

	Year	Citations
A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. Nicholas J. Petrelli, L Herrera, Youcef M. Rustum, Journal of Clinical Oncology OncologyPharmacologyClinical TrialsColorectal CancerIv Hydration	1987	449
P-glycoprotein in human sarcoma: evidence for multidrug resistance. James H. Gerlach, David R. Bell, Constantine P. Karakousis, Journal of Clinical Oncology OncologyGlycosylationMedicineGlycobiologyImmunology	1987	255
Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines Daniel G. Haller, Jim Cassidy, Stephen Clarke, Journal of Clinical Oncology	2008	252
Selective Modulation of the Therapeutic Efficacy of Anticancer Drugs by Selenium Containing Compounds against Human Tumor Xenografts Shousong Cao, Farukh A. Durrani, Youcef M. Rustum Clinical Cancer Research	2004	225
Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. William R. Greco, Hyoung Sook Park, Youcef M. Rustum PubMed Pharmaceutical ScienceDrug SynergismChemical BiologyPharmaceutical ChemistryPharmacodynamic Modeling	1990	221
Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors, Oskar S. Frankfurt, Harry K. Slocum, Youcef M. Rustum, Cytometry	1984	200
Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy. Youcef M. Rustum, Harvey D. Preisler PubMed Hematological MalignancyIntracellular RetentionOncologyMedicineMalignant Blood Disorder	1979	187
Characterization, toxicity and therapeutic efficacy of adrïamycin encapsulated in liposomes Fred C. Olson, E. Mayhew, David E. Maslow, European Journal of Cancer and Clinical Oncology Lipid PreparationNanomedicineBiochemistryPolymer-drug ConjugateTherapeutic Efficacy	1982	178
Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. Takuji Naka, Kenji Sugamura, Bonnie L. Hylander, PubMed Chemoprevention StrategyTrail Receptors Dr4ApoptosisImmunologyCell Death	2002	176
Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. Curt D. Sigmund, Kaori Okuyama, Julie R. Ingelfinger, Journal of Biological Chemistry Viral ReplicationCell ProliferationTransgenic MiceTumor BiologyTranscriptional Regulation	1990	167

Page 1